Published online Apr 14, 2024. doi: 10.3748/wjg.v30.i14.2059
Peer-review started: January 2, 2024
First decision: January 30, 2024
Revised: February 9, 2024
Accepted: March 26, 2024
Article in press: March 26, 2024
Published online: April 14, 2024
Processing time: 101 Days and 6.5 Hours
Hemorrhage associated with varices at the site of choledochojejunostomy is an unusual, difficult to treat, and often fatal manifestation of portal hypertension. So far, no treatment guidelines have been established.
We reported three patients with jejunal varices at the site of choledochojejunostomy managed by endoscopic sclerotherapy with lauromacrogol/α-butyl cyanoacrylate injection at our institution between June 2021 and August 2023. We reviewed all patient records, clinical presentation, endoscopic findings and treatment, outcomes and follow-up. Three patients who underwent pancreaticoduodenectomy with a Whipple anastomosis were examined using conventional upper gastrointestinal endoscopy for suspected hemorrhage from the afferent jejunal loop. Varices with stigmata of recent hemorrhage or active he
We conclude that endoscopic sclerotherapy with lauromacrogol/α-butyl cyanoacrylate injection can be an easy, effective, safe and low-cost treatment option for jejunal varicose bleeding at the site of choledochojejunostomy.
Core Tip: This is the first series of case reports on endoscopic sclerotherapy for venous varices at the choledochojejunostomy, including videos. From the experiences of our center, endoscopic sclerotherapy with lauromacrogol/α-butyl cyanoacrylate injection may be considered as an easy, cost-effective and efficient treatment option for hemorrhage from venous varices at the choledochojejunostomy site. For patients without complications, underlying diseases, and significant organ dysfunction, as well as those who have undergone pancreaticoduodenectomy for benign diseases, endoscopic sclerotherapy tends to have better outcomes.
